GlycoMimetics Files 8-K: Shareholder Vote, Reg FD, Other Events
Ticker: CBIO · Form: 8-K · Filed: Jun 6, 2025 · CIK: 1253689
| Field | Detail |
|---|---|
| Company | Glycomimetics INC (CBIO) |
| Form Type | 8-K |
| Filed Date | Jun 6, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-action, shareholder-vote, regulation-fd
Related Tickers: GLYC
TL;DR
GlycoMimetics filed an 8-K on June 5th covering shareholder votes, Reg FD, and other events. Details are sparse.
AI Summary
On June 5, 2025, GlycoMimetics, Inc. filed an 8-K report detailing several events. The company announced the submission of matters to a vote of its security holders, disclosed information under Regulation FD, reported other events, and included financial statements and exhibits. The filing does not specify the nature of the vote or the details of the other events.
Why It Matters
This 8-K filing indicates significant corporate actions are underway at GlycoMimetics, including matters requiring shareholder approval and regulatory disclosures.
Risk Assessment
Risk Level: medium — The filing indicates potential corporate actions and shareholder votes, which could lead to significant changes for the company, but lacks specific details on the nature of these events.
Key Players & Entities
- GlycoMimetics, Inc. (company) — Registrant
- June 5, 2025 (date) — Date of earliest event reported
FAQ
What specific matters are being submitted to a vote of GlycoMimetics' security holders?
The filing does not specify the exact matters to be voted on by security holders, only that such a submission has occurred.
What information is being disclosed under Regulation FD?
The filing states that Regulation FD Disclosure is included, but the specific content of this disclosure is not detailed within the provided text.
What are the 'Other Events' reported by GlycoMimetics?
The filing lists 'Other Events' as a category but does not provide any details about what these events entail.
Are there any financial statements or exhibits included with this 8-K filing?
Yes, the filing indicates that 'Financial Statements and Exhibits' are included as part of this report.
What is the principal executive office address and phone number for GlycoMimetics, Inc.?
The principal executive offices are located at P.O. Box 65, Monrovia, Maryland, 21770, and the registrant's telephone number is (240) 243-1201.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 6, 2025 regarding GLYCOMIMETICS INC (CBIO).